Mesoporous Silica Nanoparticles‐Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202201884 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Yi Feng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Life Science an…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 194 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
In recent years, researchers are developing novel nanoparticles for diagnostic applications using imaging techniques and for therapeutic purposes through drug delivery techniques. The unique physical and chemical properties of mesoporous silica nanoparticles (MSNs) make it possible to integrate a variety of commonly used therapeutic and imaging agents to construct a multimodal synergistic anticancer drug delivery system. Herein, recent advances in MSNs synthesis for drug delivery and smart response applications are reviewed. First, synthetic strategies for the fabrication of ordered MSNs, hollow MSNs, core–shell structured MSNs, dendritic MSNs, and biodegradable MSNs are outlined. Then, the recent research progress in designing functional MSN materials with various controlled release mechanisms in anticancer therapy is discussed, and new properties are introduced to suggest the latest design requirements as drug delivery materials. The review also highlights significant achievements in bioimaging using MSNs and their multifunctional counterparts as delivery vehicles. Finally, personal views on key directions for future work in this area are presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Life Science and Technology, University of Electronic Science and Technology of China…
- TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, No. 39 Shi-er-qiao Road, Chengdu, Sichuan, 610072, P. R. China.
- Chongqing Engineering Laboratory of Nano/Micro Biomedical Detection Technology, Chongqing University of Science and Technology, Chongqing, 401331, P. R. China.
ORCID-Profile: Yiyao Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Feng, Y., Liao, Z., Li, M., Zhang, H., Li, T., Qin, X., Li, S., Wu, C., You, F., Liao, X., Cai, L., Yang, H., & Liu, Y. (2023). Mesoporous Silica Nanoparticles‐Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202201884
Vancouver
Feng Y, Liao Z, Li M, Zhang H, Li T, Qin X, et al. Mesoporous Silica Nanoparticles‐Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202201884
BibTeX
@article{Feng2023,
author = {Feng, Yi and Liao, Zhen and Li, Mengyue and Zhang, Hanxi and Li, Tingting and Qin, Xiang and Li, Shun and Wu, Chunhui and You, Fengming and Liao, Xiaoling and Cai, Lulu and Yang, Hong and Liu, Yiyao},
title = {Mesoporous Silica Nanoparticles‐Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202201884}
}
EUVIMED